Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Public History of Education. A Brief Introduction
Is historical knowledge important for education? How can we build a shared historical knowledge with schools, communities, and education professionals? The book responds to these questions by suggesting the public history approach, as applied in education and, more generally, to all professions that are based on human relations. The public history of education refers directly to North American experiences, but at the same time it is part of a process of European cultural acceptance and re-elaboration that has one of its main points of reference in the Italian Public History Association. The objective is not to make history for the general public, but to make public history with all those interested, in a collaborative and participative context, in the quest for meaningful knowledge, directly related to the current and challenging needs of our society.
Contro la crudeltà sugli animali
Un breve saggio scritto da Alexander Pope pubblicato sul n. 61 di «The Guardian» il 21 maggio 1713, un veemente attacco al barbaro sfruttamento degli animali, inclusa la macellazione e la vivisezione. Pope riteneva che il dominio dell’uomo sulle bestie, ritenute creature inferiori, fosse il prodotto dell’industrializzazione, del profitto economico e della politica illuminista. Si batté ardentemente in favore del vegetarianesimo come unico strumento di ribellione contro tale tirannia.
Atti
None
Cancer and inflammatory diseases research: from the basics to the precision medicine
Precision medicine, or personalized medicine, is related to treatment based on the patient’s individual characteristics. To promote this personalized approach, diseases must accurately be diagnosed; specific biomarkers can predict disease evolution and optimize therapy based on each patient's characteristics such as their genetic background, lifestyle and environmental risk factors. Over the years, we have seen a revolution in pharmacotherapy and management of patients receiving personalized medicine, especially when we consider immunotherapy and specific tyrosine kinases inhibitors. Patients with inflammatory diseases, such as monogenetic diabetes and chronic kidney disease, have benefited from the progress made within the last decade related to our understanding of the genetic basis of diabetes. Similarly, patients in precision oncology, with breast, prostate and blood cancer have experienced better overall survival rates with targeted therapy such as trastuzumab (breast cancer), PARPs inhibitors (prostate cancer), imatinib, ibrutinib and venetoclax (leukemia).
